Nasal Drug Delivery Market By Dosage Form, Basis Of System, Delivery Technology and Therapeutic Application - Global Industry Analysis And Forecast To 2025

Published On : October 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC101510

Nasal Drug Delivery Market By Dosage Form (Gels & Ointments, Drops, Powder and Sprays), Basis Of System (Metered Dose, Multi-Dose and Unit Dose), Delivery Technology (Nebulizers, Spray and Other Delivery Technologies) and Therapeutic Application (Vaccinations, Congestion, Rhinitis and Other Therapeutic Applications) - Global Industry Analysis And Forecast To 2025  

Industry Outlook

The Nasal Drug Delivery is also referred to as Nasal drug administration is a course of organization in which the drugs are blown or breathe via the nose. It very well may be a type of either the systemic administration or the topical administration, as the medications in this way privately conveyed can proceed to have either simply systemic or local impacts. The sprays for nasal therapy are the locally acting medications, for example, decongestants for allergy and cold treatment, whose foundational impacts are typically insignificant. Models of fundamentally dynamic medications accessible as nasal sprays are the nicotine replacement, migraine drugs, and hormone treatments. Therefore, the Nasal Drug Delivery Market is anticipated to expand and has tremendous scope during the forecast period. The global Nasal Drug Delivery Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

Based on Dosage Form the market is segmented into Gels & Ointments, Drops, Powder and Sprays. The Sprays section is leading the market owing to the cost-effectiveness of these sprays, large dose delivery is possible, rising compliance by the patients owing to lessened irritation produced by pollen & dust, etc.

Based on Basis Of System the market is segmented into Metered Dose, Multi-Dose and Unit Dose.

Based on Delivery Technology the market is segmented into Nebulizers, Spray and Other Delivery Technologies.

Based on Therapeutic Application the market is segmented into Vaccinations, Congestion, Rhinitis and Other Therapeutic Applications. The Rhinitis section is leading the market owing to rising number of cases related to the non-allergic & allergic rhinitis, increasing use of the nasal drugs for the treatment.

Regional Insights

The North American region is leading the global Nasal Drug Delivery Market owing to factors like well-developed healthcare sector, rising expenditure by the government on the healthcare services, etc.

Nasal Drug Delivery Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Dickinson and Company
  • Merck & Co. Inc.
  • Becton
  • Novartis AG
  • Aegis Therapeutics LLC.
  • Johnson & Johnson
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • AptarGroup Inc.
  • AstraZeneca

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Nasal Drug Delivery Market, By Dosage Form, Estimates and Forecast, 2014-2025 ($Million)

o   Gels & Ointments

o   Drops

o   Powder

o   Sprays

o   Nasal Drug Delivery Market, By Basis Of System, Estimates and Forecast, 2014-2025 ($Million)

o   Metered Dose

o   Multi-Dose

o   Unit Dose

o   Nasal Drug Delivery Market, By Delivery Technology, Estimates and Forecast, 2014-2025 ($Million)

o   Nebulizers

o   Spray

o   Other Delivery Technologies

o   Nasal Drug Delivery Market, By Therapeutic Application, Estimates and Forecast, 2014-2025 ($Million)

o   Vaccinations

o   Congestion

o   Rhinitis

o   Other Therapeutic Applications

o   Nasal Drug Delivery Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Nasal Drug Delivery Market, By Country

o   U.S. Nasal Drug Delivery Market

o   Canada Nasal Drug Delivery Market

o   Mexico Nasal Drug Delivery Market

o   Europe

§  Europe Nasal Drug Delivery Market, By Country

o   Germany Nasal Drug Delivery Market

o   UK Nasal Drug Delivery Market

o   France Nasal Drug Delivery Market

o   Russia Nasal Drug Delivery Market

o   Italy Nasal Drug Delivery Market

o   Rest of Europe Nasal Drug Delivery Market

o   Asia-Pacific

§  Asia-Pacific Nasal Drug Delivery Market, By Country

o   China Nasal Drug Delivery Market

o   Japan Nasal Drug Delivery Market

o   South Korea  Nasal Drug Delivery Market

o   India Nasal Drug Delivery Market

o   Southeast Asia Nasal Drug Delivery Market

o   Rest of Asia-Pacific Nasal Drug Delivery Market

o   South America

§  South America Nasal Drug Delivery Market, By Country

o   Brazil Nasal Drug Delivery Market

o   Argentina Nasal Drug Delivery Market

o   Columbia Nasal Drug Delivery Market

o   Rest of South America Nasal Drug Delivery Market

o   Middle East and Africa

§  Middle East and Africa Nasal Drug Delivery Market, By Country

o   Saudi Arabia Nasal Drug Delivery Market

o   UAE Nasal Drug Delivery Market

o   Egypt Nasal Drug Delivery Market

o   Nigeria Nasal Drug Delivery Market

o   South Africa Nasal Drug Delivery Market

o   Rest of MEA Nasal Drug Delivery Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Nasal Drug Delivery  Market, By Dosage Form

5.1.     Introduction

5.2.     Global Nasal Drug Delivery  Revenue and Market Share by Dosage Form (2014-2018)

5.2.1.  Global Nasal Drug Delivery  Revenue and Revenue Share by Dosage Form (2014-2018)

5.3.     Gels & Ointments

5.3.1.  Global Gels & Ointments Revenue and Growth Rate (2014-2018)

5.4.     Drops

5.4.1.  Global Drops Revenue and Growth Rate (2014-2018)

5.5.     Powder

5.5.1.  Global Powder Revenue and Growth Rate (2014-2018)

5.6.     Sprays

5.6.1.  Global Sprays Revenue and Growth Rate (2014-2018)

6.       Nasal Drug Delivery  Market, By Basis Of System

6.1.     Introduction

6.2.     Global Nasal Drug Delivery  Revenue and Market Share by Basis Of System (2014-2018)

6.2.1.  Global Nasal Drug Delivery  Revenue and Revenue Share by Basis Of System (2014-2018)

6.3.     Metered Dose

6.3.1.  Global Metered Dose Revenue and Growth Rate (2014-2018)

6.4.     Multi-Dose

6.4.1.  Global Multi-Dose Revenue and Growth Rate (2014-2018)

6.5.     Unit Dose

6.5.1.  Global Unit Dose Revenue and Growth Rate (2014-2018)

7.       Nasal Drug Delivery  Market, By Delivery Technology

7.1.     Introduction

7.2.     Global Nasal Drug Delivery  Revenue and Market Share by Delivery Technology (2014-2018)

7.2.1.  Global Nasal Drug Delivery  Revenue and Revenue Share by Delivery Technology (2014-2018)

7.3.     Nebulizers

7.3.1.  Global Nebulizers Revenue and Growth Rate (2014-2018)

7.4.     Spray

7.4.1.  Global Spray Revenue and Growth Rate (2014-2018)

7.5.     Other Delivery Technologies

7.5.1.  Global Other Delivery Technologies Revenue and Growth Rate (2014-2018)

8.       Nasal Drug Delivery  Market, By Therapeutic Application

8.1.     Introduction

8.2.     Global Nasal Drug Delivery  Revenue and Market Share by Therapeutic Application (2014-2018)

8.2.1.  Global Nasal Drug Delivery  Revenue and Revenue Share by Therapeutic Application (2014-2018)

8.3.     Vaccinations

8.3.1.  Global Vaccinations Revenue and Growth Rate (2014-2018)

8.4.     Congestion

8.4.1.  Global Congestion Revenue and Growth Rate (2014-2018)

8.5.     Rhinitis

8.5.1.  Global Rhinitis Revenue and Growth Rate (2014-2018)

8.6.     Other Therapeutic Applications

8.6.1.  Global Other Therapeutic Applications Revenue and Growth Rate (2014-2018)

9.       Nasal Drug Delivery  Market, By Region

9.1.     Introduction

9.2.     Global Nasal Drug Delivery  Revenue and Market Share by Regions

9.2.1.  Global Nasal Drug Delivery  Revenue by Regions (2014-2018)

9.3.     North America Nasal Drug Delivery  by Countries

9.3.1.  North America Nasal Drug Delivery  Revenue and Growth Rate (2014-2018)

9.3.2.  North America Nasal Drug Delivery  Revenue (Million USD) by Countries (2014-2018)

9.3.3.  United States

9.3.3.1.  United States Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.3.4.  Canada

9.3.4.1.  Canada Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.3.5.  Mexico

9.3.5.1.  Mexico Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.4.     Europe Nasal Drug Delivery  by Countries

9.4.1.  Europe Nasal Drug Delivery  Revenue and Growth Rate (2014-2018)

9.4.2.  Europe Nasal Drug Delivery  Revenue (Million USD) by Countries (2014-2018)

9.4.3.  Germany

9.4.3.1.  Germany Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.4.4.  France

9.4.4.1.  France Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.4.5.  UK

9.4.5.1.  UK Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.4.6.  Russia

9.4.6.1.  Russia Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.4.7.  Italy

9.4.7.1.  Italy Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.5.     Asia-Pacific Nasal Drug Delivery  by Countries

9.5.1.  Asia-Pacific Nasal Drug Delivery  Revenue and Growth Rate (2014-2018)

9.5.2.  Asia-Pacific Nasal Drug Delivery  Revenue (Million USD) by Countries (2014-2018)

9.5.3.  China

9.5.3.1.  China Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.5.4.  Japan

9.5.4.1.  Japan Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.5.5.  Korea

9.5.5.1.  Korea Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.5.6.  India

9.5.6.1.  India Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.6.     South America Nasal Drug Delivery  by Countries

9.6.1.  South America Nasal Drug Delivery  Revenue and Growth Rate (2014-2018)

9.6.2.  South America Nasal Drug Delivery  Revenue (Million USD) by Countries (2014-2018)

9.6.3.  Brazil

9.6.3.1.  Brazil Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.6.4.  Argentina

9.6.4.1.  Argentina Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.6.5.  Columbia

9.6.5.1.  Columbia Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.7.     Middle East and Africa Nasal Drug Delivery  by Countries

9.7.1.  Middle East and Africa Nasal Drug Delivery  Revenue and Growth Rate (2014-2018)

9.7.2.  Middle East and Africa Nasal Drug Delivery  Revenue (Million USD) by Countries (2014-2018)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.7.5.  Egypt

9.7.5.1.  Egypt Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.7.7.  South Africa

9.7.7.1.  South Africa Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.7.8.  Turkey

9.7.8.1.  Turkey Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2014-2018)

10.    Company Profiles

10.1. Dickinson and Company

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. Merck & Co. Inc.

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. Becton

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. Novartis AG

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. Aegis Therapeutics LLC.

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. Johnson & Johnson

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. GlaxoSmithKline plc.

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. Pfizer Inc.

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

10.9. AptarGroup Inc.

10.9.1.      Business Overview

10.9.2.       Service Portfolio

10.9.3.      Strategic Developments

10.9.4.       Revenue and Market Share

10.10.                   AstraZeneca

10.10.1.  Business Overview

10.10.2.   Service Portfolio

10.10.3.  Strategic Developments

10.10.4.   Revenue and Market Share

11.    Global Nasal Drug Delivery  Market Competition, by Manufacturer

11.1. Global Nasal Drug Delivery  Revenue and Market Share by Manufacturer (2016-2017)

11.2. Global Nasal Drug Delivery  Price By Region (2016-2017)

11.3. Top 5 Nasal Drug Delivery  Manufacturer Market Share

11.4. Market Competition Trend

12.    Nasal Drug Delivery  Market Forecast (2018-2025)

12.1. Global Nasal Drug Delivery  Revenue (Millions USD) and Growth Rate (2018-2025)

12.2. Nasal Drug Delivery  Market Forecast by Regions (2018-2025)

12.2.1.      North America Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.1.1. United States Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.1.2. Canada Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.1.3. Mexico Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.2.      Europe Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.2.1. Germany Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.2.2. France Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.2.3. UK Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.2.4. Russia Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.2.5. Italy Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.2.6. Rest of Europe Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.3.      Asia-Pacific Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.3.1. China Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.3.2. Japan Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.3.3. Korea Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.3.4. India Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.3.5. Southeast Asia Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.3.6. Rest of Asia-Pacific Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.4.      South America Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.4.1. Brazil Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.4.2. Argentina Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.4.3. Columbia Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.4.4. Rest of South America Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.      Middle East and Africa Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.1. Saudi Arabia Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.2. United Arab Emirates Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.3. Egypt Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.4. Nigeria Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.5. South Africa Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.6. Turkey Nasal Drug Delivery  Market Forecast (2018-2025)

12.2.5.7. Rest of Middle East and Africa Nasal Drug Delivery  Market Forecast (2018-2025)

12.3. Nasal Drug Delivery  Market Forecast by Dosage Form (2018-2025)

12.3.1.      Nasal Drug Delivery  Forecast by Dosage Form (2018-2025)

12.3.2.      Nasal Drug Delivery  Market Share Forecast by Dosage Form (2018-2025)

12.4. Nasal Drug Delivery  Market Forecast by Basis Of System (2018-2025)

12.4.1.      Nasal Drug Delivery  Forecast by Basis Of System (2018-2025)

12.4.2.      Nasal Drug Delivery  Market Share Forecast by Basis Of System (2018-2025)

12.5. Nasal Drug Delivery  Market Forecast by Delivery Technology (2018-2025)

12.5.1.      Nasal Drug Delivery  Forecast by Delivery Technology (2018-2025)

12.5.2.      Nasal Drug Delivery  Market Share Forecast by Delivery Technology (2018-2025)

12.6. Nasal Drug Delivery  Market Forecast by Therapeutic Application (2018-2025)

12.6.1.      Nasal Drug Delivery  Forecast by Therapeutic Application (2018-2025)

12.6.2.      Nasal Drug Delivery  Market Share Forecast by Therapeutic Application (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Nasal Drug Delivery Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Nasal Drug Delivery Revenue and Revenue Share by Dosage Form (2014-2018)
Figure Global Gels & Ointments Revenue and Growth Rate (2014-2018)
Figure Global Drops Revenue and Growth Rate (2014-2018)
Figure Global Powder Revenue and Growth Rate (2014-2018)
Figure Global Sprays Revenue and Growth Rate (2014-2018)
Table Global Nasal Drug Delivery Revenue and Revenue Share by Basis Of System (2014-2018)
Figure Global Metered Dose Revenue and Growth Rate (2014-2018)
Figure Global Multi-Dose Revenue and Growth Rate (2014-2018)
Figure Global Unit Dose Revenue and Growth Rate (2014-2018)
Table Global Nasal Drug Delivery Revenue and Revenue Share by Delivery Technology (2014-2018)
Figure Global Nebulizers Revenue and Growth Rate (2014-2018)
Figure Global Spray Revenue and Growth Rate (2014-2018)
Figure Global Other Delivery Technologies Revenue and Growth Rate (2014-2018)
Table Global Nasal Drug Delivery Revenue and Revenue Share by Therapeutic Application (2014-2018)
Figure Global Vaccinations Revenue and Growth Rate (2014-2018)
Figure Global Congestion Revenue and Growth Rate (2014-2018)
Figure Global Rhinitis Revenue and Growth Rate (2014-2018)
Figure Global Other Therapeutic Applications Revenue and Growth Rate (2014-2018)
Table Global Nasal Drug Delivery Revenue by Regions (2014-2018)
Figure North America Nasal Drug Delivery Growth Rate (2014-2018)
Figure North America Nasal Drug Delivery Revenue and Growth Rate (2014-2018)
Figure North America Nasal Drug Delivery by Countries (2014-2018)
Figure North America Nasal Drug Delivery Revenue (Million USD) by Countries (2014-2018)
Figure United States Nasal Drug Delivery Growth Rate (2014-2018)
Figure United States Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Nasal Drug Delivery Growth Rate (2014-2018)
Figure Canada Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Nasal Drug Delivery Growth Rate (2014-2018)
Figure Mexico Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Nasal Drug Delivery Growth Rate (2014-2018)
Figure Europe Nasal Drug Delivery Revenue and Growth Rate (2014-2018)
Figure Europe Nasal Drug Delivery by Countries (2014-2018)
Figure Europe Nasal Drug Delivery Revenue (Million USD) by Countries (2014-2018)
Figure Germany Nasal Drug Delivery Growth Rate (2014-2018)
Figure Germany Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Nasal Drug Delivery Growth Rate (2014-2018)
Figure France Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Nasal Drug Delivery Growth Rate (2014-2018)
Figure UK Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Nasal Drug Delivery Growth Rate (2014-2018)
Figure Russia Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Nasal Drug Delivery Growth Rate (2014-2018)
Figure Italy Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Nasal Drug Delivery Growth Rate (2014-2018)
Figure Rest of Europe Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Nasal Drug Delivery Growth Rate (2014-2018)
Figure Asia-Pacific Nasal Drug Delivery Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Nasal Drug Delivery by Countries (2014-2018)
Figure Asia-Pacific Nasal Drug Delivery Revenue (Million USD) by Countries (2014-2018)
Figure China Nasal Drug Delivery Growth Rate (2014-2018)
Figure China Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Nasal Drug Delivery Growth Rate (2014-2018)
Figure Japan Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Nasal Drug Delivery Growth Rate (2014-2018)
Figure Korea Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Nasal Drug Delivery Growth Rate (2014-2018)
Figure India Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Nasal Drug Delivery Growth Rate (2014-2018)
Figure Southeast Asia Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Nasal Drug Delivery Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Nasal Drug Delivery Growth Rate (2014-2018)
Figure South America Nasal Drug Delivery Revenue and Growth Rate (2014-2018)
Figure South America Nasal Drug Delivery by Countries (2014-2018)
Figure South America Nasal Drug Delivery Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Nasal Drug Delivery Growth Rate (2014-2018)
Figure Brazil Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Nasal Drug Delivery Growth Rate (2014-2018)
Figure Argentina Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Nasal Drug Delivery Growth Rate (2014-2018)
Figure Columbia Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Nasal Drug Delivery Growth Rate (2014-2018)
Figure Rest of South America Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Nasal Drug Delivery Growth Rate (2014-2018)
Figure Middle East and Africa Nasal Drug Delivery Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Nasal Drug Delivery by Countries (2014-2018)
Figure Middle East and Africa Nasal Drug Delivery Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Nasal Drug Delivery Growth Rate (2014-2018)
Figure Saudi Arabia Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Nasal Drug Delivery Growth Rate (2014-2018)
Figure United Arab Emirates Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Nasal Drug Delivery Growth Rate (2014-2018)
Figure Egypt Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Nasal Drug Delivery Growth Rate (2014-2018)
Figure Nigeria Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Nasal Drug Delivery Growth Rate (2014-2018)
Figure South Africa Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Nasal Drug Delivery Growth Rate (2014-2018)
Figure Turkey Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Nasal Drug Delivery Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2014-2018)
Table Dickinson and Company Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Inc. Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Becton Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aegis Therapeutics LLC. Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc. Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AptarGroup Inc. Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Nasal Drug Delivery Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Nasal Drug Delivery Market Share by Manufacturer
Figure Global Nasal Drug Delivery Revenue and Market Share by Manufacturer
Table Global Nasal Drug Delivery Price by Region (2016-2017)
Figure Top 5 Nasal Drug Delivery Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Nasal Drug Delivery Revenue (Millions USD) and Growth Rate (2018-2025)
Table Nasal Drug Delivery Market Forecast by Regions (2018-2025)
Figure North America Nasal Drug Delivery Market Forecast (2018-2025)
Figure United States Nasal Drug Delivery Market Forecast (2018-2025)
Figure Canada Nasal Drug Delivery Market Forecast (2018-2025)
Figure Mexico Nasal Drug Delivery Market Forecast (2018-2025)
Figure Europe Nasal Drug Delivery Market Forecast (2018-2025)
Figure Germany Nasal Drug Delivery Market Forecast (2018-2025)
Figure France Nasal Drug Delivery Market Forecast (2018-2025)
Figure UK Nasal Drug Delivery Market Forecast (2018-2025)
Figure Russia Nasal Drug Delivery Market Forecast (2018-2025)
Figure Italy Nasal Drug Delivery Market Forecast (2018-2025)
Figure Rest of Europe Nasal Drug Delivery Market Forecast (2018-2025)
Figure Asia-Pacific Nasal Drug Delivery Market Forecast (2018-2025)
Figure China Nasal Drug Delivery Market Forecast (2018-2025)
Figure Japan Nasal Drug Delivery Market Forecast (2018-2025)
Figure Korea Nasal Drug Delivery Market Forecast (2018-2025)
Figure India Nasal Drug Delivery Market Forecast (2018-2025)
Figure Southeast Asia Nasal Drug Delivery Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Nasal Drug Delivery Market Forecast (2018-2025)
Figure South America Nasal Drug Delivery Market Forecast (2018-2025)
Figure Brazil Nasal Drug Delivery Market Forecast (2018-2025)
Figure Argentina Nasal Drug Delivery Market Forecast (2018-2025)
Figure Columbia Nasal Drug Delivery Market Forecast (2018-2025)
Figure Rest of South America Nasal Drug Delivery Market Forecast (2018-2025)
Figure Middle East and Africa Nasal Drug Delivery Market Forecast (2018-2025)
Figure Saudi Arabia Nasal Drug Delivery Market Forecast (2018-2025)
Figure United Arab Emirates Nasal Drug Delivery Market Forecast (2018-2025)
Figure Egypt Nasal Drug Delivery Market Forecast (2018-2025)
Figure Nigeria Nasal Drug Delivery Market Forecast (2018-2025)
Figure South Africa Nasal Drug Delivery Market Forecast (2018-2025)
Figure Turkey Nasal Drug Delivery Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Nasal Drug Delivery Market Forecast (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Dosage Form (2018-2025)
Figure Global Nasal Drug Delivery Market Share Forecast by Dosage Form (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Dosage Form (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Basis Of System (2018-2025)
Figure Global Nasal Drug Delivery Market Share Forecast by Basis Of System (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Basis Of System (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Delivery Technology (2018-2025)
Figure Global Nasal Drug Delivery Market Share Forecast by Delivery Technology (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Delivery Technology (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Therapeutic Application (2018-2025)
Figure Global Nasal Drug Delivery Market Share Forecast by Therapeutic Application (2018-2025)
Figure Global Nasal Drug Delivery Forecast by Therapeutic Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*